herpes simplex virus (hsv) (human herpesvirus 1 & 2) ivds
abbott australasia pty ltd diagnostic division - ct749 - herpes simplex virus (hsv) (human herpesvirus 1 & 2) ivds - for the determination of herpes simplex virus 1 and/or herpes simplex virus 2 (hsv1 and/or hsv2) markers in human clinical specimens.
epstein-barr virus (human herpesvirus 4) ivds
abbott australasia pty ltd molecular division - ct747 - epstein-barr virus (human herpesvirus 4) ivds - the abbott ebv assay is an in vitro polymerase chain reaction (pcr) assay to quantitate epstein-barr virus (ebv) dna in human edta plasma. the assay is intended for use as an aid in the diagnosis and management of ebv in transplant patients and other immunocompromised patients.
vir combination (influenzinum- 2022-2023, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode liquid
deseret biologicals, inc. - influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (uv, formaldehyde inactivated) (unii: 34c49nv47p) (influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) hemagglutinin antigen (uv, formaldehyde inactivated) - unii:ngl844y7x6), influenza a virus a/darwin/9/2021 ivr-228 (h3n2) antigen (uv, formaldehyde inactivated) (unii: p483j7gx6d) (influenza a virus a/darwin/9/2021 ivr-228 (h3n2) hemagglutinin antigen (uv, formaldehyde inactivated) - unii:grn94tp8yv), influenza b virus b/austria/1359417/2021 bvr-26 antigen (uv, formaldehyde inactivated) (unii: tbv2ppg6ef) (influenza b virus b/austria/1359417/2021 bvr-26 hemagglutinin antigen (uv, formaldehyde inactivated) - unii:28eah8253x), influenza b virus b/phuket/3073/2013 antigen (uv, formaldehyde inactivated) (unii: h2198f8zna) (influenza b virus b/phuket/3073/2013 hemagglutinin antigen (uv, formaldehyde inactivated) - unii:3vsf1bf3sr), human herpesvirus 1 (unii: 22g38p19rl) (human herpesvirus 1 - unii:22g38p19rl), human herpesvirus 2 (unii: 74j6dnh49u) (human herpesvirus 2 - unii:74j6dnh49u), human herpesvirus 6 (unii: 4ix4vp35cr) (human herpesvirus 6 - unii:4ix4vp35cr), human herpesvirus 5 (unii: 7coi029e6k) (human herpesvirus 5 - unii:7coi029e6k), hepatitis b virus (unii: 77h9em77p7) (hepatitis b virus - unii:77h9em77p7), human adenovirus e serotype 4 strain cl-68578 antigen (unii: fkd3duk39i) (human adenovirus e serotype 4 strain cl-68578 - unii:fkd3duk39i), human adenovirus b serotype 7 strain 55142 antigen (unii: tm54l796sn) (human adenovirus b serotype 7 strain 55142 antigen - unii:tm54l796sn), human herpesvirus 4 (unii: 2a26yw7pnx) (human herpesvirus 4 - unii:2a26yw7pnx) - for temporary relief of symptoms related to general viral infection, including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to general viral infection, including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.
varicella zoster virus (human herpesvirus 3) ivds
diasorin australia pty ltd - ct756 - varicella zoster virus (human herpesvirus 3) ivds - for the in vitro qualitative detection of varicella zoster virus (vzv) viral dna present in cerebrospinal fluid, or in cutaneous and mucocutaneous lession swabs from patients with signs and symptoms of vzv infection. for use as an aid in the diagnosis of vzv infection of the cns and, where applicable, in the differential diagnosis of vzv infection.
vectormune hvt ibd suspension for injection
biomune company, united states - herpesvirus of turkey (hvt), serotype 3, strain fc-126 as a vector for vp2 gene of infectious bursal disease virus (ibdv) - suspension for injection - 2280 pfu/dose
vectormune hvt ibd suspension for injection
biomune company, united states - herpesvirus of turkey (hvt), serotype 3, strain fc-126 as a vector for vp2 gene of infectious bursal disease virus (ibdv) - suspension for injection - 2280 pfu/dose
vectormune hvt ibd suspension for injection
biomune company, united states - herpesvirus of turkey (hvt), serotype 3, strain fc-126 as a vector for vp2 gene of infectious bursal disease virus (ibdv) - suspension for injection - 2280 pfu/dose
sylvant
recordati netherlands b.v. - siltuximab - giant lymph node hyperplasia - immunosuppressants - sylvant is indicated for the treatment of adult patients with multicentric castleman’s disease (mcd who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.,
sylvant siltuximab (rmc) 400mg powder for injection vial
recordati rare diseases australia pty ltd - siltuximab, quantity: 400 mg - injection, powder for - excipient ingredients: polysorbate 80; sucrose; histidine - sylvant is indicated for the treatment of patients with multicentric castleman's disease (mcd) who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.
sylvant siltuximab (rmc) 100mg powder for injection vial
recordati rare diseases australia pty ltd - siltuximab, quantity: 100 mg - injection, powder for - excipient ingredients: histidine; polysorbate 80; sucrose - sylvant is indicated for the treatment of patients with multicentric castleman's disease (mcd) who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.